Home -> Law Blog Directory -> Patent Law Blogs -> Patent Docs

Patent Law

: Patent Docs

Congressional Fact-finding on Follow-on Biologics

By Donald Zuhn, Kevin Noonan, Chris Singer, Sherri Oslick, and Jason Derry

By Kevin E. Noonan -- The Subcommittee on Health of the House of Representatives' Committee on Energy and Commerce recently solicited comments and information on so-called "follow-on biologics" (FOBs) from stakeholders and other interested parties. The Subcommittee on Health's letter, signed by Subcommittee chairman Frank Pallone, Jr. (D-NJ, 6th Dist.) and ranking member Nathan Deal (R-GA, 9th Dist.), elicited dozens of responses, from innovator and generic pharmaceutical companies (including Amgen and Biogen Idec on one hand and Teva Pharmaceutical and Mylan Labs on the other); industry groups like the Biotechnology Industrial Organization (BIO) and the Generic Pharmaceutical Association (GPhA); benefits...

Full post as published by Patent Docs on August 14, 2008 (boomark / email).